Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

NCT03131895 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: 30 mg dexlansoprazole capsules manufactured at TOB
DRUG: 30 mg dexlansoprazole capsules manufactured at TPC
DRUG: 60 mg dexlansoprazole capsules manufactured at TOB
DRUG: 60 mg dexlansoprazole capsules manufactured at TPC

Sponsor

Takeda